The family of a 16-year-old from a small northern Ontario community, who was seriously injured when her ex-boyfriend allegedly hit her with his vehicle and then attacked her with a sword ...
William Blair notes that VK2735 stands out as a promising candidate for big pharma due to its Phase 3 readiness, the potential for tablet formulation, and Viking’s amylin program, which is set ...